• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives

Exploring N-methoxy-N,4-dimethylpentanamide (CAS No. 625852-40-6): Properties, Applications, and Industry Insights

N-methoxy-N,4-dimethylpentanamide (CAS No. 625852-40-6) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This amide derivative, characterized by its methoxy and dimethyl functional groups, offers versatile reactivity, making it a valuable intermediate in synthetic chemistry. Researchers are increasingly exploring its potential in drug discovery, particularly for modulating bioavailability and metabolic stability—key challenges in modern small-molecule drug development.

The compound's molecular structure (C₈H₁₇NO₂) combines lipophilic and polar motifs, a balance highly sought after in medicinal chemistry. Recent studies highlight its role in optimizing prodrug formulations, addressing common issues like poor solubility—a trending topic in AI-driven drug design forums. With the rise of computational chemistry tools, researchers now use molecular docking simulations to predict how 625852-40-6 interacts with biological targets, accelerating high-throughput screening processes.

In agrochemical applications, N-methoxy-N,4-dimethylpentanamide derivatives show promise as plant growth regulators. Its structural flexibility allows modifications to enhance systemic acquired resistance (SAR) in crops—a hot topic in sustainable agriculture discussions. Industry reports suggest growing patent filings involving this compound, particularly for eco-friendly pesticide formulations, aligning with global demands for green chemistry solutions.

Analytical characterization of CAS 625852-40-6 typically involves HPLC-MS and NMR spectroscopy, techniques frequently searched by quality control professionals. The compound's stability under various pH conditions makes it suitable for formulation development, another area where researchers actively share data on scientific collaboration platforms. Notably, its logP value (predicted ~1.8) positions it favorably within Lipinski's Rule of Five parameters—a recurring theme in pharmacokinetics optimization queries.

Manufacturing N-methoxy-N,4-dimethylpentanamide requires precise control of amide coupling reactions, a process often discussed in process chemistry circles. Recent innovations in continuous flow synthesis have improved yields while reducing solvent waste, addressing environmental health and safety (EHS) concerns. Suppliers increasingly highlight these green synthesis approaches in response to buyer preferences for sustainable sourcing.

From a commercial perspective, the global fine chemicals market shows steady demand for 625852-40-6, with applications expanding into electronic materials and lubricant additives. Market analysts note growing interest from Asia-Pacific manufacturers, particularly for high-purity grades (>98%). Quality specifications often focus on residual solvent levels and heavy metal content—critical parameters for GMP compliance in pharmaceutical applications.

Emerging research explores structure-activity relationships (SAR) of N-methoxy-N,4-dimethylpentanamide analogs, with particular attention to hydrogen bond donor/acceptor modifications. These studies frequently appear in bioisostere replacement discussions, a technique gaining traction in fragment-based drug discovery. The compound's conformational flexibility also makes it a candidate for allosteric modulator development—an area seeing increased NIH funding allocations.

Storage and handling recommendations for CAS 625852-40-6 emphasize moisture-sensitive properties, with best practices suggesting argon-filled containers for long-term stability. These protocols align with laboratory safety standards increasingly searched by QC/QA professionals. Technical datasheets typically include DSC thermal analysis data, important for formulation scientists working on solid-dosage forms.

Looking ahead, N-methoxy-N,4-dimethylpentanamide is poised to play a role in next-generation therapeutics, especially in targeted protein degradation strategies. Its structural scaffold offers opportunities for PROTAC linker development—an explosive growth area in oncological research. As AI-assisted retrosynthesis tools become mainstream, expect faster innovation cycles for derivatives of this versatile chemical building block.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)